Publication | Closed Access

Specific inhibition of the subunits of ribonucleotide reductase as a new approach to combination chemotherapy

Specific InhibitionOncologyCombination ChemotherapyBiochemistryRibonucleotide ReductaseMedicineAldo-keto ReductaseAnti-cancer AgentPharmacologyProtein SynthesisInhibitory ActivityCancer ResearchDrug Discovery